Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIMMER-YOUNG: Phase 3 study of XW003 in Chinese adolescents with overweight or obesity
CTR20263596Phase 3Active
- Sponsor
- Sciwind Biosciences
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ecnoglutide in obesity, Overweight, sponsored by Sciwind Biosciences. Started Sep 2026; status: active.
02
Drugs
ecnoglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20263596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263596.